Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Abstract Long-term effects of continuous subcutaneous apomorphine infusion (CSAI) on health-related quality of life (HRQoL) and predictors of CSAI discontinuation are poorly known. Data from consecutive advanced Parkinson’s disease patients treated in routine care were retrospectively collected over...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Bruna Meira, Bertrand Degos, Elise Corsetti, Mohamed Doulazmi, Emeline Berthelot, Clara Virbel-Fleischman, Pauline Dodet, Aurélie Méneret, Louise-Laure Mariani, Cécile Delorme, Florence Cormier-Dequaire, David Bendetowicz, Nicolas Villain, Clément Tarrano, Lise Mantisi, Hélène Letrillart, Céline Louapre, Eavan McGovern, Yulia Worbe, David Grabli, Marie Vidailhet, Elodie Hainque, Emmanuel Roze
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/f346fe136aee4bfcb71a0c5f818bfacc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Documents similaires